From fa4f33fa80b5c0c3bc55dec30c5be1aeadafdf75 Mon Sep 17 00:00:00 2001 From: justinbader92 Date: Mon, 3 Aug 2026 23:27:13 +1000 Subject: [PATCH] Add Drug Repurposing Market Report: Market Size, Share and Future Trends --- ...arket-Report%3A-Market-Size%2C-Share-and-Future-Trends.md | 5 +++++ 1 file changed, 5 insertions(+) create mode 100644 Drug-Repurposing-Market-Report%3A-Market-Size%2C-Share-and-Future-Trends.md diff --git a/Drug-Repurposing-Market-Report%3A-Market-Size%2C-Share-and-Future-Trends.md b/Drug-Repurposing-Market-Report%3A-Market-Size%2C-Share-and-Future-Trends.md new file mode 100644 index 0000000..7cb4b4e --- /dev/null +++ b/Drug-Repurposing-Market-Report%3A-Market-Size%2C-Share-and-Future-Trends.md @@ -0,0 +1,5 @@ +The Drug Repurposing Market continues to evolve through advancements in pharmaceutical science that enable existing medicines to address additional disease indications. Rather than relying solely on new molecule discovery, researchers evaluate approved drugs with established clinical data to reduce development risk and accelerate therapeutic availability. Increasing prevalence of chronic diseases, cancer, metabolic disorders, and infectious diseases has strengthened demand for efficient treatment development strategies. Scientific progress in molecular biology, genomics, and systems pharmacology continues enhancing researchers' ability to discover innovative therapeutic opportunities. + +https://www.marketresearchfuture.com/reports/drug-repurposing-market-22086 + +Growing adoption of artificial intelligence and predictive modeling has significantly improved identification of drug-target interactions and biological pathways associated with multiple diseases. Pharmaceutical companies, biotechnology organizations, and academic research centers continue forming strategic partnerships that accelerate clinical validation and commercialization. Regulatory agencies remain supportive of therapies addressing unmet healthcare needs, encouraging continued investment in repurposing initiatives. As healthcare systems worldwide focus on improving treatment accessibility and affordability, drug repurposing is expected to remain an essential pillar of pharmaceutical innovation and patient-centered care. \ No newline at end of file